Baxter Bros Inc Albemarle Corp Transaction History

Baxter Bros Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 26, 2024	SELL	$108.73 - $146.89 $10,873 - $14,688	-100 Reduced 5.17%	1,835 $241,000
Q4 2023 May 17, 2024	BUY	$113.26 - $170.8 $11,326 - $17,080	100 Added 5.45%	1,935 $279,000
Q4 2023 Feb 06, 2024	SELL	$113.26 - $170.8 $792 - $1,195	-7 Reduced 0.36%	1,935 $279,000
Q3 2023 May 17, 2024	BUY	$162.63 - $243.44 $17,401 - $26,048	107 Added 5.83%	1,942 $330,000
Q3 2023 Oct 23, 2023	BUY	$162.63 - $243.44 $112,539 - $168,460	692 Added 55.36%	1,942 $330,000
Q2 2023 Aug 14, 2023	BUY	$172.91 - $232.22 $216,137 - $290,275	1,250 New	1,250 $278,000

928

104M

8.36M

14.3M

Ticker ALB
Exchange NYSE
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 117,129,000
Market Cap $12.6B
Description
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...

Get notified when there are updates to the investment portfolio of Baxter Bros Inc, based on Form 13F filings with the SEC.

Stay updated on Baxter Bros Inc with notifications on news.